Revolution Medicines, Inc.
BICYCLIC HETEROARYL COMPOUNDS AND USES THEREOF
Last updated:
Abstract:
The present disclosure is directed to modulators of SOS1 and their use in the treatment of disease. Also disclosed are pharmaceutical compositions comprising the same.
Status:
Application
Type:
Utility
Filling date:
2 Mar 2020
Issue date:
5 May 2022